拜耳起诉强生,指控其对一种用于治疗前列腺癌的药物进行虚假广告。根据在曼哈顿联邦法院提交的诉状,强生对拜耳的Nubeqa药物发起虚假广告活动,以推广和展示其自身药物Erleada所谓的优越性。拜耳寻求三倍赔偿、收回所谓的不当得利,以及禁止强生涉嫌虚假广告的禁制令。
拜耳起诉强生,指控其对一种用于治疗前列腺癌的药物进行虚假广告。根据在曼哈顿联邦法院提交的诉状,强生对拜耳的Nubeqa药物发起虚假广告活动,以推广和展示其自身药物Erleada所谓的优越性。拜耳寻求三倍赔偿、收回所谓的不当得利,以及禁止强生涉嫌虚假广告的禁制令。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.